Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MQSA Reauthorization Bill Calls For IoM, GAO Mammography Studies

This article was originally published in The Gray Sheet

Executive Summary

FDA would be required to complete accreditation criteria on digital mammography standards under the "Mammography Quality Standards Reauthorization Act" of 2002 (HR 4888)

You may also be interested in...



MQSA Panel Urges “Relevant” Equipment Testing To Limit Facility Downtime

FDA needs to identify a way to evaluate mammography equipment components that does not incapacitate testing facilities, according to the agency's National Mammography Quality Assurance Advisory Committee

Cosmetic And Personal Care Trademark Review: 9 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016739

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel